FLT3, CD32, PU.1, ERG, uPAR, and TAP2 Are Strongly Associated with the Progression of Chronic Myeloid Leukemia and Combination of Small Interference RNA of FLT3 and STI571 Synergistically Induced Apoptosis of K562 Cells
Kyung Im Kim(Korea University), Sung‐Soo Yoon(Seoul National University Hospital), Chansu Lee(Samsung Medical Center), Young-Yiul Lee(Hanyang University Seoul Hospital), Kwang‐Sung Ahn(Seoul National University Hospital), Juwon Park(Seoul National University), Byoung Kook Kim(Seoul National University), Jung Mi Oh(Seoul National University)
Cited by 1
Related Papers
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study
|The Lancet|2023|194
The novel AKT inhibitor afuresertib shows favorable safety, pharmacokinetics, and clinical activity in multiple myeloma
|Blood|2014|140